US Stock MarketDetailed Quotes

GlaxoSmithKline (GSK)

Watchlist

54.440
-1.190-2.14%

Close Apr 24 15:59 ET

54.400
-0.040-0.07%

Post 20:01 ET

108.66BMarket Cap14.56P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GlaxoSmithKline (GSK) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Total revenue

4.11%32.67B

6.17%8.62B

6.68%8.55B

1.29%7.99B

2.08%7.52B

3.46%31.38B

0.81%8.12B

-1.66%8.01B

9.84%7.88B

5.93%7.36B

Operating revenue

4.11%32.67B

6.17%8.62B

6.68%8.55B

1.29%7.99B

2.08%7.52B

3.46%31.38B

0.81%8.12B

-1.66%8.01B

9.84%7.88B

5.93%7.36B

Cost of revenue

-0.34%9.02B

3.83%2.66B

-5.80%2.26B

2.03%2.17B

-1.68%1.94B

5.64%9.05B

5.83%2.56B

5.50%2.4B

9.83%2.12B

1.39%1.97B

Gross profit

5.92%23.65B

7.25%5.96B

12.00%6.29B

1.02%5.82B

3.45%5.58B

2.60%22.33B

-1.35%5.56B

-4.43%5.62B

9.84%5.76B

7.69%5.39B

Operating expense

-8.78%15.31B

33.34%4.46B

-31.88%3.7B

-7.73%3.8B

-13.84%3.36B

16.42%16.79B

-25.11%3.34B

38.21%5.43B

32.56%4.12B

33.39%3.9B

Selling and administrative expenses

-17.49%9.09B

-0.90%2.64B

-41.08%2.24B

-13.18%2.14B

-0.81%2.07B

17.37%11.02B

-0.56%2.66B

65.51%3.8B

8.69%2.47B

-2.61%2.09B

-General and administrative expense

-17.49%9.09B

-0.90%2.64B

-41.08%2.24B

-13.18%2.14B

-0.81%2.07B

17.37%11.02B

-0.56%2.66B

65.51%3.8B

8.69%2.47B

-2.61%2.09B

Research and development costs

17.56%7.53B

15.71%2.35B

15.76%1.69B

37.03%2.02B

1.95%1.46B

2.86%6.4B

-0.78%2.03B

-7.37%1.46B

10.14%1.48B

13.81%1.43B

Other operating expenses

----

-97.94%11M

--9M

---1.18B

-8.72%335M

--318M

--533M

Operating profit

50.45%8.34B

-32.07%1.51B

1,271.96%2.59B

22.90%2.02B

48.72%2.22B

-24.55%5.54B

89.00%2.22B

-90.30%189M

-23.12%1.65B

-28.43%1.49B

Net non-operating interest income expense

-4.98%-633M

-28.21%-250M

-13.71%-141M

10.67%-134M

19.40%-108M

17.96%-603M

22.31%-195M

21.52%-124M

1.32%-150M

22.99%-134M

Non-operating interest income

-6.67%56M

-164.29%-74M

-18.75%26M

108.33%50M

68.75%54M

25.00%60M

26.32%-28M

33.33%32M

-27.27%24M

10.34%32M

Non-operating interest expense

7.34%687M

20.83%174M

7.05%167M

5.75%184M

-2.41%162M

-11.72%640M

-7.10%144M

-14.29%156M

-5.95%174M

-18.23%166M

Total other finance cost

-91.30%2M

----

-60.34%23M

----

Other net income (expense)

Special income (charges)

34.06%-813M

----

-75.14%-1.23B

-74.89%-1.23B

--0

-Less：Restructuring and merger&acquisition

-66.82%581M

----

121.37%1.75B

----

-Less:Other special charges

144.79%232M

----

-495.40%-518M

----

Income before tax

112.86%7.4B

68.74%950M

3,737.50%2.46B

26.22%1.89B

55.57%2.11B

-42.66%3.48B

48.55%563M

-96.43%64M

-24.76%1.5B

-28.95%1.36B

Income tax

111.41%1.11B

259.68%223M

31,300.00%312M

26.18%241M

22.63%336M

-30.42%526M

426.32%62M

-100.39%-1M

-21.07%191M

-0.72%274M

Net income

113.11%6.29B

45.11%727M

3,198.46%2.14B

26.23%1.65B

63.92%1.77B

-44.40%2.95B

25.88%501M

-95.76%65M

-25.27%1.3B

-33.72%1.08B

Net income continuous Operations

113.11%6.29B

45.11%727M

3,198.46%2.14B

26.23%1.65B

63.92%1.77B

-44.40%2.95B

25.88%501M

-95.76%65M

-25.27%1.3B

-33.72%1.08B

Net income discontinuous operations

----

--0

----

Minority interest income

52.39%573M

4.60%91M

6.50%131M

54.96%203M

322.86%148M

-1.05%376M

81.25%87M

75.71%123M

8.26%131M

-75.18%35M

Net income attributable to the parent company

121.98%5.72B

53.62%636M

3,570.69%2.01B

23.02%1.44B

55.26%1.62B

-47.75%2.58B

18.29%414M

-103.96%-58M

-27.77%1.17B

-29.80%1.05B

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

121.98%5.72B

53.62%636M

3,570.69%2.01B

23.02%1.44B

55.26%1.62B

-47.75%2.58B

18.29%414M

-103.96%-58M

-27.77%1.17B

-29.80%1.05B

Basic earnings per share

123.26%2.822

56.44%0.316

3,664.29%0.998

23.26%0.71

54.47%0.794

-48.03%1.264

17.44%0.202

-103.88%-0.028

-28.18%0.576

-30.16%0.514

Diluted earnings per share

123.15%2.776

56.00%0.312

3,607.14%0.982

23.16%0.702

54.72%0.786

-48.12%1.244

17.65%0.2

-103.93%-0.028

-28.21%0.57

-30.41%0.508

Dividend per share

6.17%1.292

10.49%0.3271

6.43%0.3184

6.97%0.323

1.16%0.3235

8.15%1.217

5.45%0.296

10.70%0.2992

3.82%0.3019

12.82%0.3198

Currency Unit

GBP

Accounting Standards

NonUS-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Total revenue	4.11%32.67B	6.17%8.62B	6.68%8.55B	1.29%7.99B	2.08%7.52B	3.46%31.38B	0.81%8.12B	-1.66%8.01B	9.84%7.88B	5.93%7.36B
Operating revenue	4.11%32.67B	6.17%8.62B	6.68%8.55B	1.29%7.99B	2.08%7.52B	3.46%31.38B	0.81%8.12B	-1.66%8.01B	9.84%7.88B	5.93%7.36B
Cost of revenue	-0.34%9.02B	3.83%2.66B	-5.80%2.26B	2.03%2.17B	-1.68%1.94B	5.64%9.05B	5.83%2.56B	5.50%2.4B	9.83%2.12B	1.39%1.97B
Gross profit	5.92%23.65B	7.25%5.96B	12.00%6.29B	1.02%5.82B	3.45%5.58B	2.60%22.33B	-1.35%5.56B	-4.43%5.62B	9.84%5.76B	7.69%5.39B
Operating expense	-8.78%15.31B	33.34%4.46B	-31.88%3.7B	-7.73%3.8B	-13.84%3.36B	16.42%16.79B	-25.11%3.34B	38.21%5.43B	32.56%4.12B	33.39%3.9B
Selling and administrative expenses	-17.49%9.09B	-0.90%2.64B	-41.08%2.24B	-13.18%2.14B	-0.81%2.07B	17.37%11.02B	-0.56%2.66B	65.51%3.8B	8.69%2.47B	-2.61%2.09B
-General and administrative expense	-17.49%9.09B	-0.90%2.64B	-41.08%2.24B	-13.18%2.14B	-0.81%2.07B	17.37%11.02B	-0.56%2.66B	65.51%3.8B	8.69%2.47B	-2.61%2.09B
Research and development costs	17.56%7.53B	15.71%2.35B	15.76%1.69B	37.03%2.02B	1.95%1.46B	2.86%6.4B	-0.78%2.03B	-7.37%1.46B	10.14%1.48B	13.81%1.43B
Other operating expenses	----	----	----	----	-97.94%11M	--9M	---1.18B	-8.72%335M	--318M	--533M
Operating profit	50.45%8.34B	-32.07%1.51B	1,271.96%2.59B	22.90%2.02B	48.72%2.22B	-24.55%5.54B	89.00%2.22B	-90.30%189M	-23.12%1.65B	-28.43%1.49B
Net non-operating interest income expense	-4.98%-633M	-28.21%-250M	-13.71%-141M	10.67%-134M	19.40%-108M	17.96%-603M	22.31%-195M	21.52%-124M	1.32%-150M	22.99%-134M
Non-operating interest income	-6.67%56M	-164.29%-74M	-18.75%26M	108.33%50M	68.75%54M	25.00%60M	26.32%-28M	33.33%32M	-27.27%24M	10.34%32M
Non-operating interest expense	7.34%687M	20.83%174M	7.05%167M	5.75%184M	-2.41%162M	-11.72%640M	-7.10%144M	-14.29%156M	-5.95%174M	-18.23%166M
Total other finance cost	-91.30%2M	----	----	----	----	-60.34%23M	----	----	----	----
Other net income (expense)
Special income (charges)	34.06%-813M	----	----	----	----	-75.14%-1.23B	-74.89%-1.23B	--0	--0	--0
-Less：Restructuring and merger&acquisition	-66.82%581M	----	----	----	----	121.37%1.75B	----	----	----	----
-Less:Other special charges	144.79%232M	----	----	----	----	-495.40%-518M	----	----	----	----
Income before tax	112.86%7.4B	68.74%950M	3,737.50%2.46B	26.22%1.89B	55.57%2.11B	-42.66%3.48B	48.55%563M	-96.43%64M	-24.76%1.5B	-28.95%1.36B
Income tax	111.41%1.11B	259.68%223M	31,300.00%312M	26.18%241M	22.63%336M	-30.42%526M	426.32%62M	-100.39%-1M	-21.07%191M	-0.72%274M
Net income	113.11%6.29B	45.11%727M	3,198.46%2.14B	26.23%1.65B	63.92%1.77B	-44.40%2.95B	25.88%501M	-95.76%65M	-25.27%1.3B	-33.72%1.08B
Net income continuous Operations	113.11%6.29B	45.11%727M	3,198.46%2.14B	26.23%1.65B	63.92%1.77B	-44.40%2.95B	25.88%501M	-95.76%65M	-25.27%1.3B	-33.72%1.08B
Net income discontinuous operations	----	----	----	----	----	--0	----	----	----	----
Minority interest income	52.39%573M	4.60%91M	6.50%131M	54.96%203M	322.86%148M	-1.05%376M	81.25%87M	75.71%123M	8.26%131M	-75.18%35M
Net income attributable to the parent company	121.98%5.72B	53.62%636M	3,570.69%2.01B	23.02%1.44B	55.26%1.62B	-47.75%2.58B	18.29%414M	-103.96%-58M	-27.77%1.17B	-29.80%1.05B
Preferred stock dividends
Other preferred stock dividends	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	121.98%5.72B	53.62%636M	3,570.69%2.01B	23.02%1.44B	55.26%1.62B	-47.75%2.58B	18.29%414M	-103.96%-58M	-27.77%1.17B	-29.80%1.05B
Basic earnings per share	123.26%2.822	56.44%0.316	3,664.29%0.998	23.26%0.71	54.47%0.794	-48.03%1.264	17.44%0.202	-103.88%-0.028	-28.18%0.576	-30.16%0.514
Diluted earnings per share	123.15%2.776	56.00%0.312	3,607.14%0.982	23.16%0.702	54.72%0.786	-48.12%1.244	17.65%0.2	-103.93%-0.028	-28.21%0.57	-30.41%0.508
Dividend per share	6.17%1.292	10.49%0.3271	6.43%0.3184	6.97%0.323	1.16%0.3235	8.15%1.217	5.45%0.296	10.70%0.2992	3.82%0.3019	12.82%0.3198
Currency Unit	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

United Microelectronics

Middle East conflict spreads to the stock market! How should investors respond?

Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm